ChromaDex Statistics
Total Valuation
ChromaDex has a market cap or net worth of $439.40 million. The enterprise value is $410.05 million.
Important Dates
The last earnings date was Thursday, October 31, 2024, after market close.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ChromaDex has 76.55 million shares outstanding. The number of shares has increased by 2.28% in one year.
| Shares Outstanding | 76.55M |
| Shares Change (YoY) | +2.28% |
| Shares Change (QoQ) | +2.92% |
| Owned by Insiders (%) | 30.50% |
| Owned by Institutions (%) | 22.31% |
| Float | 49.39M |
Valuation Ratios
The trailing PE ratio is 291.73 and the forward PE ratio is 51.02.
| PE Ratio | 291.73 |
| Forward PE | 51.02 |
| PS Ratio | 4.73 |
| Forward PS | 3.91 |
| PB Ratio | 12.73 |
| P/FCF Ratio | 108.23 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 318.36, with an EV/FCF ratio of 101.00.
| EV / Earnings | 276.13 |
| EV / Sales | 4.47 |
| EV / EBITDA | 318.36 |
| EV / EBIT | 917.33 |
| EV / FCF | 101.00 |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.95 |
| Quick Ratio | 2.27 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 1.12 |
| Debt / FCF | 0.71 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.82% and return on invested capital (ROIC) is 0.82%.
| Return on Equity (ROE) | 4.82% |
| Return on Assets (ROA) | 0.51% |
| Return on Capital (ROIC) | 0.82% |
| Revenue Per Employee | $864,792 |
| Profits Per Employee | $14,009 |
| Employee Count | 106 |
| Asset Turnover | 1.67 |
| Inventory Turnover | 3.05 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +287.84% in the last 52 weeks. The beta is 1.88, so ChromaDex's price volatility has been higher than the market average.
| Beta (5Y) | 1.88 |
| 52-Week Price Change | +287.84% |
| 50-Day Moving Average | 3.58 |
| 200-Day Moving Average | 2.99 |
| Relative Strength Index (RSI) | 81.82 |
| Average Volume (20 Days) | 2,312,524 |
Short Selling Information
The latest short interest is 2.96 million, so 3.87% of the outstanding shares have been sold short.
| Short Interest | 2.96M |
| Short Previous Month | 3.20M |
| Short % of Shares Out | 3.87% |
| Short % of Float | 6.00% |
| Short Ratio (days to cover) | 10.17 |
Income Statement
In the last 12 months, ChromaDex had revenue of $91.67 million and earned $1.49 million in profits. Earnings per share was $0.02.
| Revenue | 91.67M |
| Gross Profit | 56.33M |
| Operating Income | 447,000 |
| Pretax Income | -1.35M |
| Net Income | 1.49M |
| EBITDA | 1.29M |
| EBIT | 447,000 |
| Earnings Per Share (EPS) | $0.02 |
Full Income StatementBalance Sheet
The company has $32.25 million in cash and $2.90 million in debt, giving a net cash position of $29.35 million or $0.38 per share.
| Cash & Cash Equivalents | 32.25M |
| Total Debt | 2.90M |
| Net Cash | 29.35M |
| Net Cash Per Share | $0.38 |
| Equity (Book Value) | 34.37M |
| Book Value Per Share | 0.45 |
| Working Capital | 34.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.18 million and capital expenditures -$115,000, giving a free cash flow of $4.06 million.
| Operating Cash Flow | 4.18M |
| Capital Expenditures | -115,000 |
| Free Cash Flow | 4.06M |
| FCF Per Share | $0.05 |
Full Cash Flow StatementMargins
Gross margin is 61.45%, with operating and profit margins of 0.49% and 1.62%.
| Gross Margin | 61.45% |
| Operating Margin | 0.49% |
| Pretax Margin | 1.62% |
| Profit Margin | 1.62% |
| EBITDA Margin | 1.41% |
| EBIT Margin | 0.49% |
| FCF Margin | 1.14% |
Dividends & Yields
ChromaDex does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.28% |
| Shareholder Yield | -2.28% |
| Earnings Yield | 0.34% |
| FCF Yield | 0.92% |
Analyst Forecast
The average price target for ChromaDex is $7.00, which is 21.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 21.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on April 13, 2016. It was a reverse split with a ratio of 0.3333333:1.
| Last Split Date | Apr 13, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.3333333:1 |
Scores
ChromaDex has an Altman Z-Score of 2.7 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.7 |
| Piotroski F-Score | 6 |